跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Plasil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Plasil
Approved
STANDARD
Plasil
Sanofi S.p.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d5c03dd0c69868be
Company
Sanofi S.p.A.
Type
Standard
Approval Details
Approval Id
d5c03dd0c69868be
Drug Approval Philippines Name
Plasil
Product Name
Plasil
Registration Number
DRP-6568
Brand Name
Plasil
Generic Name
Metoclopramide (As Hydrochloride)
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Sanofi S.p.A.
Importer
Sanofi-Aventis Philippines, Inc.
Issuance Date
25 January 2024
Expiry Date
30 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d5c03dd0c69868be
Type
Standard
Back to Philippines FDA Approvals